Product Name |
MF |
CAS |
Details |
2-Methoxy-5-methylpyridin-4-amine |
C7H10N2O |
1260663-96-4 |
|
1,2,3-Benzenetricarboxylic acid |
C9H8O7 |
732304-21-1 |
|
methyl quinoline-7-carboxylate |
C11H9NO2 |
51552-68-2 |
|
2-Amino-3-Nitro pyridine |
C5H5N3O2 |
4214-75-9 |
|
2-Nitromesitylene, (1,3,5-Trimethyl-2-nitrobenzene) |
C9H11NO2 |
603-71-4 |
|
1,2-DIPHENYLCYCLOPROPEN-3-ONE |
C15H10O |
886-38-4 |
|
6-Methoxy-4-methylcoumarin |
C11H10O3 |
6295-35-8 |
|
5-Chloro-N-[4-[(5S)-5-[[[(5-chloro-2- thienyl) carbonyl]amino]methyl]-2-oxo-3- oxazolidinyl]phenyl]-N-[2-[2-oxo-2-[[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl] amino]ethoxy]ethyl]-2-thiophenecarboxamide |
C38H36Cl2N6O10S2 |
1632463-24-1 |
|
Lithium phenyl (2,4,6-trimethylbenzoyl) phosphinate |
C16H18LiO3P |
85073-19-4 |
|
1-(bromomethyl)-4-methoxybenzene; (4-Methoxybenzyl bromide) |
C8H9BrO |
2746-25-0 |
|
(R)-10-(2,4,5-Trifluorobenzyl)-3-(trifluoromethyl)- 6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4- c][1,4,7]triazecine-8,12(5H,9H)-dione |
C16H13F6N5O2 |
2088771-61-1 |
|
Olopatadine isopropyl ester impurity (Z-isomer) |
C24H29NO3 |
1206456-44-1 |
|
6,7-dimethoxy-2-piperazin-1-ylquinazolin-4-amine;dihydrochloride |
C19H25N5O4 |
60548-08-5 |
|
5,7-Dimethoxycoumarin |
C11H10O4 |
487-06-9 |
|
2-METHYL-3-NITRO BENZYL ALCOHOL |
C8H9NO3 |
23876-13-3 |
|
7-Methylcoumarin |
C10H8O2 |
2445-83-2 |
|
3-ethylphenol |
C8H10O |
620-17-7 |
|
2-phenoxyethanamine |
C8H11NO |
1758-46-9 |
|
2,2-Dimethyl-1-phenyl-1-propanol |
C11H16O |
3835-64-1 |
|
4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2’-(1H- tetazol-5-yl)[1,1’-biphenyl]-4-yl]methyl]-1H-imidazole- 5-carboxylic Acid |
C24H26N6O3 |
144689-24-7 |
|
Coumestrol (Synthetic) |
C15H8O5 |
479-13-0 |
|
Methyl 2-cyclohexyl-2-hydroxy-2-phenylacetate |
C15H20O3 |
10399-13-0 |
|
N-[3-(2-Formamido-5-methoxyphenyl)-3-oxopropyl] acetamide |
C13H16N2O4 |
52450-38- 1 |
|
2-Hydroxy-6-methyl-4-(methylsulfanyl)pyridine-3-carbonitrile |
C8H8N2OS |
57663-05-5 |
|
5-bromopyridine-2-carbonitrile |
C5H2BrN3 |
38275-57-9 |
|
4,6-Dichloro-2-methylsulfanylpyrimidine |
C5H4Cl2N2S |
6299-25-8 |
|
4-Chloro-3-(chlorosulfonyl)benzoic acid |
C7H4Cl2O4S |
2494-79-3 |
|
Gossypin 85% |
C21H20O13 |
652-78-8 |
|
Ethyl 2-cyclohexyl-2-hydroxy-2-phenylacetate |
C16H22O3 |
31197-69-0 |
|
8-Benzyl-3-nortropanone oxime |
C14H18N2O |
76272-34-9 |
|
2-Azaspiro[4.5]decan-3-one |
C9H15NO |
64744-50-9 |
|
(S)-Benzyl 4-amino-2-((tert-butoxycarbonyl)amino)-4-oxobutanoate |
C16H22N2O5 |
13512-57-7 |
|
(+)-10,2-Camphorsultam |
C10H17NO2S |
108448-77-7 |
|
3-METHOXY-5-NITROBENZOIC ACID |
C8H7NO5 |
78238-12-7 |
|
Harmalol hydrochloride |
C12H13ClN2O |
6028-07-5 |
|
DL- Penicillamine racemic |
C5H11NO2S |
52-66-4 |
|
(4S,12aS)-N-[(2,4-Difluorophenyl)methyl]- 3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8- dioxo-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide; (4-epi-Dolutegravir) |
C20H19F2N3O5 |
1357289-37-2 |
|
Chlorogenic acid – trans |
C16H18O9 |
327-97-9 |
|
3,5-Dichlorobenzoyl Nitrile |
C8H3Cl2NO |
99567-74-5 |
|
2,4-DIBROMO-6-METHYLANILINE |
C7H7Br2N |
30273-41-7 |
|
3,3-diphenylpropyl acrylate |
C18H18O2 |
1246752-04-4 |
|
6-Bromo coumarin-3-carboxylic acid |
C10H5BrO4 |
2199-87-3 |
|
1-Chloro-3,5-dimethyladamantane; Memantine USP Related Compound C |
C12H19Cl |
707-36-8 |
|
2-Amino-6-methyl-5-nitro pyridine |
C6H7N3O2 |
22280-62-2 |
|
Ketorolac tromethamine impurity-2 |
C19H24N2O6 |
74103-07-4 |
|
2-Methyl-5-nitro-1-(2-oxiranylmethyl)-1H-imidazole |
C7H9N3O3 |
16773-52-7 |
|
Vanillic acid |
C8H8O4 |
121-34-6 |
|
Ethyl methyl sulfone |
C3H8O2S |
594-43-4 |
|
8-Nonen-1-ol |
C9H18O |
13038-21-6 |
|
5-Chloro-3-[3-(2,3-dihydro-2-oxo-1H-benzimidazol-1- yl)propyl]-1-[1-[3-(2,3-dihydro-2-oxo-1H-benzimidazol- 1-yl)propyl]-4-piperidinyl]-1,3-dihydro-2H-benzimidazol-2-one |
C32H34ClN7O3 |
1614255-34-3 |
|
7-Benzyloxy-4-trifluoromethycoumarin |
C17H11F3O3 |
220001-53-6 |
|
Gabapentine Hydrochloride |
C9H17NO2 |
60142-96-3 |
|
N-Formyl Memantine; Memantine USP impurity E |
C13H21NO |
351329-88-9 |
|
11-Fluoro desloratadine |
C19H20ClFN2 |
298220-99-2 |
|
N-(3-Chloro-2-methylphenyl)-2-hydroxynicotinamide |
C13H11ClN2O2 |
72646-00-5 |
|
(Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(E,3R)-3-hydroxy- 5-phenylpent-1-enyl]cyclopentyl]-N-ethylhept-5- enamide |
C25H37NO4 |
1163135-92-9 |
|
N-(4-Aminophenyl)-N-methyl-2-(4-methylpiperazin-1-yl)acetamide |
C14H22N4O |
262368-30-9 |
|
N-[3-[3-Cyclopropyl-5-(2-fluoro-4-iodoanilino)-6,8- dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1- yl]phenyl]acetamide |
C26H23FIN5O4 |
871700-17-3 |
|
4-(Diethylamino)but-2-ynyl 2-hydroxy-2,2- diphenylacetate |
C22H25NO3 |
14943-53-4 |
|
1-(((Cyclohexyloxy)carbonyl)oxy)ethyl 2-ethoxy-1-((2'- (2-ethyl-2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)- 1H-benzo[d]imidazole-7-carboxylate |
C35H38N6O6 |
914613-36-8 |
|
(5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 5-prop-1-en-2- yl-2-propyl-3-[[4-[2-(2H-tetrazol-5- yl)phenyl]phenyl]methyl]imidazole-4-carboxylate |
C29H28N6O5 |
879562-26-2 |
|
3-methyl-2-Amino-benzonitrile |
C8H8N2 |
69797-49-5 |
|
(αS)-6-Methoxy-α-methyl-2-naphthaleneacetic Acid Methyl Este |
C15H16O3 |
26159-35-3 |
|
(4aR,4bS,6aS,7S,9aS,9bS,11aR)-4a,6a-Dimethyl-2-oxo- 2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro- 1H-indeno[5,4-f]quinoline-7-carboxylic acid; (Dutasteride EP Impurity A) |
C19H27NO3 |
104239-97-6 |
|
7-hydroxy-3-phenyl coumarin |
C15H10O3 |
6468-96-8 |
|
(S)-(+)-Abscisic acid |
C15H20O4 |
21293-29-8 |
|
1-(2-Bromo-6-chlorophenyl)-1,3-dihydro-2H-indol-2-one |
C14H9BrClNO |
1219112-85-2 |
|
4-(5-(4-(pentyloxy)phenyl)isoxazol-3-yl)benzoic acid |
C21H21NO4 |
179162-55-1 |
|
Dicyclopentyl (3,3'-((2-methoxy-4-((o- tolylsulfonyl)carbamoyl)phenyl)methylene)bis(1- methyl-1H-indole-5,3-diyl))dicarbamate |
C46H49N5O8S |
1160235-24-4 |
|
2-Bromo-1-(3-chlorophenyl)propan-1-one |
C9H8BrClO |
34911-51-8 |
|
4-Chloro-N'-(4-chlorobenzoyl)-N-(4-methoxyphenyl)benzohydrazide |
C21H16Cl2N2O3 |
402849-27-8 |
|
[4-(1,2,4,5-tetrazin-3-yl)phenyl] methanamine hydrochloride; Tetrazine-Amine |
C9H10ClN5 |
1345866-68-3 |
|
4-Methyl-7-hydroxy-8-nitrocoumarin |
C10H7NO5 |
19037-69-5 |
|
2-[(2RS)-2-Aminobut-3-enyl]propanedioic acid (as per EP) ; 2-(2-aminobut-3-enyl)malonic acid |
C7H11NO4 |
1378466-25-1 |
|
2,5-Bis(1-methylethyl)phenol |
C12H18O |
35946-91-9 |
|
2-Amino-3,5-Dibromo pyridine |
C5H4Br2N2 |
35486-42-1 |
|
3-Dimethylamino-1-propyne |
C5H9N |
7223-38-3 |
|
6-Methyl-m-toluenesulfonyl chloride, |
C8H9ClO3S |
88040-86-2 |
|
Di-tert-butyl Sulfide |
C8H18S |
107-47-1 |
|
1-(3,5-dimethoxyphenyl)piperazine hydrochloride |
C12H19ClN2O2 |
1993148-46-1 |
|
4-Ethoxycarbonyl-3-ethoxyphenylacetic Acid |
C13H16O5 |
99469-99- 5 |
|
3-nitro-4-phenoxy-5-sulfamoylbenzoic acid |
C13H10N2O7S |
28328-53-2 |
|
Dimethyl 2,6-dimethyl-4-(2-nitrophenyl)pyridine-3,5- dicarboxylate |
C17H16N2O6 |
67035-22- 7 |
|
6-[2-(3,4-Dihydro-4,4-dimethyl-2H-1-benzothiopyran-6- yl)ethynyl]-,3-Pyridinecarboxylic Acid Methyl Ester |
C20H19NO2S |
1332579-70-0 |
|
2-Methoxynaphthalene |
C11H10O |
93-04-9 |
|
2,3-Dibromobutane-1,4-diol |
C4H8Br2O2 |
20163-90-0 |
|
2-Methoxy-3-Nitropyridine |
C6H6N2O3 |
20265-35-4 |
|
Quercetin |
C15H14O9 |
6151-25-3 |
|
Salicylaldehyde azine-99% |
C14H12N2O2 |
959-36-4 |
|
2-Chloro-4-(trifluoromethyl)aniline |
C7H5ClF3N |
39885-50-2 |
|
Harmaline hydrochloride dihydrate |
C13H17ClN2O2 |
6027-98-1 |
|
3-fluoropyridin-4-amine |
C5H5FN2 |
2247-88-3 |
|
trans-Cyclobutane-1,2-dicarboxylic acid |
C6H8O4 |
1124-13-6 |
|
6-Methyl-3-pyridinecarboxaldehyde |
C7H7NO2 |
65873-72-5 |
|
3-piperazin-1-yl-1, 2-benzisothiazole hydrochloride |
C11H14ClN3S |
87691-88-1 |
|
2-Nitrocinnamaldehyde |
C9H7NO3 |
1466-88-2 |
|
Butanoic acid, 4-chloro-3,3-dimethoxy-, methyl ester |
C7H13ClO4 |
2682-39-5 |
|
Methyl N-[5-propylsulfinyl)-1H-benzo[d]imidazol-2- ylcarbamate; (Albendazole-sulfoxide ) |
C12H15N3O3S |
54029-12-8 |
|
(4aS,9bR)-6-Bromo-1H,2H,3H,4H,4aH,5H,9bH-pyrido[4,3-b]indole S-Mandelic acid |
C19H21BrN2O3 |
1059630-13-5 |
|
Methyl (1S*,2R*,3R*)-3-hydroxy-2-[(E)-4-hydroxy-4- methyl-1-octenyl]-5-oxocyclopentane-heptanoate |
C22H38O5 |
1788085-78-8 |
|